Tekisha Freeman
Family · Fayetteville, NCNPI 1861035289
Payments from drug & device makers
Across 131 payments — averaging $15.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$289
- Amgen$221
- Novo Nordisk$191
- Takeda Pharmaceuticals U.S.A., Inc.$102
- Merck$98
- Sanofi-aventis U.S. LLC$92
- plus $1K from 25 others
What the payments were for
- Food & beverage$2,006100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 24 | $289 |
| Amgen(2 entities) | 15 | $221 |
| Novo Nordisk | 11 | $191 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $102 |
| Merck | 7 | $98 |
| Sanofi-aventis U.S. LLC | 6 | $92 |
| Bayer | 6 | $86 |
| Esperion Therapeutics, Inc. | 4 | $86 |
| Paratek Pharmaceuticals, Inc. | 6 | $84 |
| AstraZeneca | 5 | $67 |
| Boehringer Ingelheim | 4 | $66 |
| GSK | 4 | $59 |
| Biohaven Pharmaceuticals, Inc. | 2 | $53 |
| Mylan Specialty L.p. | 3 | $50 |
| Lilly USA, LLC | 3 | $45 |
| Amarin Pharma, Inc. | 3 | $45 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $42 |
| Exact Sciences | 2 | $40 |
| Daiichi Sankyo Inc. | 2 | $36 |
| Novartis | 2 | $34 |
| Ironwood Pharmaceuticals, Inc | 2 | $31 |
| Johnson & Johnson | 2 | $30 |
| Eisai Inc. | 2 | $25 |
| Dexcom, Inc. | 1 | $25 |
| Masimo Corporation | 1 | $24 |
| Forte Bio-pharma LLC | 1 | $19 |
| Pfizer | 1 | $15 |
| Corcept Therapeutics | 1 | $14 |
| Dynavax Technologies Corporation | 1 | $13 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $11 |
How this compares
$2,006 in reported general payments places this provider in the 80th percentile of 4,522 family providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 11 | $10,595 |
| PaxlovidNirmatrelvir/Ritonavir | 18 | $1,429 |
| Naproxen | 61 | $560 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 68 | $530 |
| Fluticasone Propionate | 47 | $478 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 22 | $460 |
| Prednisone | 72 | $427 |
| Ondansetron OdtOndansetron | 21 | $282 |
| Doxycycline Hyclate | 37 | $264 |
| Gabapentin | 15 | $196 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 41 | $176 |
| Azithromycin | 57 | $172 |
| Mupirocin | 20 | $165 |
| Cephalexin | 28 | $155 |
| Cyclobenzaprine Hcl | 38 | $154 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $191 | $10,59511 claims |
| PfizerPaxlovid | $15 | $1,42918 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,522 family providers in North Carolina.
Other family in Fayetteville
- Leslie ByrneFayetteville$482K
- Melissa DoyleFayetteville$38K
- Michele CerraRaleigh$332K
- Anne LakeArchdale$306K
- Carrie PettitRaleigh$298K
- Nicole RothmanDurham$268K
- Meredith LeaYanceyville$253K
- Jennifer GibbsRaleigh$216K
- Juanita PerkinsDurham$213K
- Teresa DossWilmington$137K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.